RonIsWrong Posted - 2 weeks ago

$DYN RA Capital - grabs 5.2M shares ($136M) 6.36% ownership on 3/25

StockConsultant Posted - 2 weeks ago

$DYN Dyne Therapeutics stock narrow range breakout watch, https://stockconsultant.com/?DYN

AboveTheHorizon Posted - 03/28/24

$DYN give me a buyout already

Stock_Titan Posted - 03/27/24

$DYN Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer https://www.stocktitan.net/news/DYN/dyne-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-4nohi82lffhn.html

RonIsWrong Posted - 03/27/24

$DYN let's see if it pushes past the previous high here

FlynancialAnalyst Posted - 03/27/24

$DYN $2.19B mc $XBI name catching volume off an early in the morning test of 10 wk SMA today. Accumulation wk near ATHs last week 93.66% institutionally owned, short float % rapidly declining from 24.25% to start the year, to 11.72% today #SqueezeIt

Theflash88 Posted - 03/27/24

$DYN Something is cooking.

Stock_Titan Posted - 03/27/24

$DYN Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium https://www.stocktitan.net/news/DYN/dyne-therapeutics-to-present-at-the-cantor-virtual-muscular-aqdesco7vqp1.html

erevnon Posted - 03/26/24

Oppenheimer reiterates Dyne Therapeutics $DYN at Outperform and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

XavierXV Posted - 03/25/24

$RAPT was waiting to buy into $DYN and with the departure of their CEO they hired the ex Vice President of Biogen to step in...wow. another golden opportunity. Knowledge is king

DonCorleone77 Posted - 03/25/24

$DYN Dyne Therapeutics CEO Joshua Brumm to step down, John Cox to succeed Dyne Therapeutics announced the appointment of John Cox as president, CEO and a member of the Board of Directors, effective immediately. He succeeds Joshua Brumm, who has chosen to step down from these roles to pursue a career in healthcare investing. Mr. Brumm will serve as an advisor to Dyne to help ensure a seamless transition. Most recently, Cox served as CEO of Repertoire Immune Medicines and its predecessor from 2019 until 2022.

Stock_Titan Posted - 03/25/24

$DYN Dyne Therapeutics Announces CEO Transition https://www.stocktitan.net/news/DYN/dyne-therapeutics-announces-ceo-zf2r5zidw5x6.html

AboveTheHorizon Posted - 03/21/24

$DYN yee haw

Doorkey Posted - 03/21/24

$DYN Been waiting on a dip. 25$????

BobBuran Posted - 03/21/24

Thursday This is the only posts today showing a total of about 40 of my buy stop orders above the market for today. Already bot past ten minutes: $WGS $DYN #Stocks

LioBa Posted - 1 month ago

$DYN still above the EMA 21

JoeAlerts Posted - 1 month ago

$DYN she moved up nicely form $16s and could see more later

Stock_Titan Posted - 1 month ago

$DYN Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days https://www.stocktitan.net/news/DYN/dyne-therapeutics-to-present-at-stifel-2024-virtual-cns-1p38f7ox4pyn.html

insiderbuyingselling Posted - 1 month ago

$DYN new insider selling: 109601 shares. http://insiderbuyingselling.com/?t=DYN

insiderbuyingselling Posted - 1 month ago

$DYN new insider selling: 2081 shares. http://insiderbuyingselling.com/?t=DYN

insiderbuyingselling Posted - 1 month ago

$DYN new insider selling: 429730 shares. http://insiderbuyingselling.com/?t=DYN

Theflash88 Posted - 1 month ago

$DYN It’s coming soon

insiderbuyingselling Posted - 1 month ago

$DYN new insider selling: 1591 shares. http://insiderbuyingselling.com/?t=DYN

valueforme Posted - 1 month ago

$rna and $dyn - similar indications, similar approaches to address them, similar stock price appreciation recently. Who else is the neurology oligonucleotide race but has no attention from retail at all? $TRDA is one of them. DM1 program is partnered to Vertex and is currently in Phase 1. DMD programs - one in phase 1, several more preclinical. Delivery tech is completely different from RNA and DYN.

erevnon Posted - 1 month ago

Chardan Capital maintains Dyne Therapeutics $DYN at Buy and raises the price target from $20 to https://marketsblock.com/stock-upgrades-and-downgrades/

cklee88 Posted - 1 month ago

$RNA $DYN $PEPG similar pipelines, 4x in 4 months, seriously overbought...

xbibackto70s Posted - 1 month ago

$DYN earnings=destroyed

xbibackto70s Posted - 1 month ago

$DYN buyout 👍🏻 ya ok w these fing scam rumors

Theflash88 Posted - 1 month ago

$DYN Adding..

DonCorleone77 Posted - 1 month ago

$DYN Dyne Therapeutics reports Q4 EPS ($1.09), consensus (92c) "We've had an exciting start to 2024 highlighted by Dyne's first clinical data demonstrating proof-of-concept in our DM1 and DMD programs that validated the promise of the FORCE(TM) platform in developing targeted therapeutics for people living with rare muscle diseases. We were thrilled to see dose-dependent results in our ACHIEVE trial in DM1 as well as meaningful improvement in myotonia at the lowest dose, and in our DELIVER trial to exceed the level of dystrophin production reported for the standard of care for DMD exon 51 with a fraction of the dose. The strength of these data formed the foundation of the $345 million offering we completed in January 2024, which has extended our projected cash runway through 2025," said Joshua Brumm, president and chief executive officer of Dyne. "In 2024, we are focused on leveraging the favorable safety profiles for both DYNE-101 and DYNE-251 and the adaptive nature...."